Dietary intake of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in children - a workshop report

Autor: Andreu Palou, Ans Eilander, Sheila M. Innis, Berthold Koletzko, Ricardo Uauy, Saskia J. M. Osendarp, Frans J. Kok, Gerard Hornstra, Peter L. Zock, Diego Moretti
Jazyk: angličtina
Rok vydání: 2010
Předmět:
030309 nutrition & dietetics
pregnancy outcomes
Medicine (miscellaneous)
growth measures
law.invention
0302 clinical medicine
Randomized controlled trial
law
Food science
Child
Health Education
Reproductive health
chemistry.chemical_classification
0303 health sciences
Nutrition and Dietetics
Fishes
Eicosapentaenoic acid
3. Good health
Eicosapentaenoic Acid
Docosahexaenoic acid
Child
Preschool

fish-oil supplementation
randomized controlled-trials
Health education
lipids (amino acids
peptides
and proteins)

double-blind
Child Nutritional Physiological Phenomena
Polyunsaturated fatty acid
medicine.medical_specialty
Docosahexaenoic Acids
food sources
030209 endocrinology & metabolism
Health Promotion
Biology
attention-deficit/hyperactivity disorder
03 medical and health sciences
Dietary Fats
Unsaturated

current knowledge
Environmental health
medicine
Animals
Humans
Preventive healthcare
VLAG
Global Nutrition
Wereldvoeding
business.industry
Nutritional Requirements
Congresses as Topic
risk pregnancies
Diet
Health promotion
chemistry
Preventive Medicine
business
polyunsaturated fatty-acids
Zdroj: British Journal of Nutrition, 103(6), 923-928
British Journal of Nutrition 103 (2010) 6
ISSN: 0007-1145
DOI: 10.1017/s0007114509991851
Popis: There is controversy whether children should have a dietary supply of preformed long-chain polyunsaturated n-3 fatty acids EPA and DHA. The aims of the workshop were to review evidence for a possible benefit of a preformed EPA and/or DHA supply, of data required to set desirable intakes for children aged 2–12 years, and of research priorities. The authors concluded that EPA and DHA intakes per kg body weight may often be low in 2- to 12-year-old children, relative to intakes per kg body weight of breast-fed infants and adult intakes, but reliable data are scarce. Little information is available that increasing dietary intakes of EPA or DHA in children has benefits to physical or mental function or other health endpoints. Studies addressing EPA and DHA intakes and tissue status among groups of children with different dietary habits, and measures of relevant development and health endpoints, are needed for developing potential advice on desirable intakes of EPA and/or DHA in children. At this time it appears prudent to advise that dietary intakes in childhood are consistent with future eating patterns supporting adult health, such as prevention of metabolic disorders and CVD, supporting immune function, and reproductive health. In conclusion, the available information relating dietary EPA and DHA intakes in children aged 2–12 years to growth, development and health is insufficient to derive dietary intake recommendations for EPA and DHA. Adequately designed studies addressing dietary intakes, measures of status and relevant functional or health effects across this age group are needed.
Databáze: OpenAIRE